Runa Mithani

Statistics

Publications

Citations

565

H-Index

Active since

2022

Affiliations

Moderna Therapeutics (United States)(Current)

Runa Mithani is an author at Moderna Therapeutics (United States) specializing in viral vaccines, messenger ribonucleic acid (mrna) vaccine formulations, and infectious diseases.

Publications per year

2022–2024

Publications

Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults

Eleanor Wilson, Jaya Goswami, Abdullah H Baqui et al. · New England Journal of Medicine · 2023 · 453 citations · Full text

Veterinary Medicine, Geriatric Medicine, Infectious Diseases +17

Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older Adults

Christine A. Shaw, Brandon Essink, Charles Harper et al. · The Journal of Infectious Diseases · 2024 · 55 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Safety, Tolerability, and Immunogenicity of an mRNA-Based Respiratory Syncytial Virus Vaccine in Healthy Young Adults in a Phase 1 Clinical Trial

Christine A. Shaw, Runa Mithani, Archana Kapoor et al. · The Journal of Infectious Diseases · 2024 · 34 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmaceutics +17

234. Safety and Immunogenicity of mRNA-1345, an mRNA-Based RSV Vaccine in Younger and Older Adult Cohorts: Results from a Phase 1, Randomized Clinical Trial

Grace Chen, Runa Mithani, Archana Kapoor et al. · Open Forum Infectious Diseases · 2022 · 23 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

1–4 of 4